Ga. Comp. R. & Regs. r. 480-7-.03. Drug Wholesale Distribution Licensing Requirements.
GeorgiaRegulations
Ask Donna
How this section applies to your facts.
Rules and Regulations of the State of Georgia › Department 480 RULES OF GEORGIA STATE BOARD OF PHARMACY › Chapter 480-7 PERMITS. › Ga. Comp. R. & Regs. r. 480-7-.03
Text
(1) Every drug wholesale distributor, wherever located, who engages in drug wholesale
distribution into, out of, or within the State of Georgia must be licensed by the Georgia
State Board of Pharmacy in accordance with the laws and regulations of this State before
engaging in wholesale distribution of prescription drugs.
(2) Minimum Required Information for Licensure: The Board requires the following from
each wholesale drug distributor as part of the initial licensing procedure and as part of any
renewal of such license:
(a) The name, full business address, and telephone number of the licensee;
(b) All trade or business names used by the licensee;
(c) Address, telephone numbers, and the names of contact persons for the facility used
by the licensee for the storage, handling, and distribution of prescription drugs;
(d) The type of ownership or operations (i.e., partnership, corporation, or sole
proprietorship); and
(e) The name(s) of the owner and/or operator of the licensee, including:
1. If a person, the name of the person;
2. If a partnership, the name of each partner, and the name of the partnership;
3. If a corporation, the name and title of each corporate officer and director,
the corporate names, and the name of the incorporation; and the name of the
parent company, if any;
4. If a sole proprietorship, the full name of the sole proprietorship and the
name of the business entity.
(f) Where operations are conducted at more than one location by a single drug
wholesale distributor, each such location shall be licensed by the Board.
(g) Every drug wholesale distributor in this state, which is licensed by the Board, is
required to be located in a commercially zoned business district and possess the
appropriate local business license in order to conduct business. No drug wholesale
distributor may be located in or operate out of a residential dwelling, building, or
location, or a building, dwelling or location attached to a residential location. A
drug wholesale distributor located in a hospital pharmacy or a retail pharmacy is
deemed to meet this requirement.
(3) Applications for Licensure.
(a) Registration of a drug wholesaler distributor will be considered on the basis of the
application filed with the Board, fee paid, and a report from the Director of the
GDNA certifying the applicant possesses the necessary qualifications of a license.
(b) Application fees shall not be refundable.
(c) No license issued under this Rule shall be transferred or assigned by a licensee.
However, the Board may reassign a license to a licensee or successor entity by
request upon application to the Board.
(d) Prior to any change in name, ownership, mode of operation or location of a
pharmacy, licensees shall apply for approval of such change by submitting a
Board-approved application to the Board and paying a fee. To comply with the
requirements of this Rule, applications must be made and approved prior to the
change.
1. A change of ownership is deemed to have occurred upon the closure of any
transaction which results in a change to any of the ownership information
submitted to the Board as part of the licensee's initial application for
licensure or renewal of licensure.
(e) Licensees shall notify the Board in writing of the occurrence of any change to any
of the information submitted to the Board as part of the licensee's initial
application for licensure or application for renewal of licensure. This shall not
apply to any event the occurrence of which these rules require immediate
notification to the Board, in which event such immediate notification shall be
made.
(f) Licenses are renewed for two years and expire on June 30th of each odd numbered
year and may be renewed upon the payment of the required fee for each place of
business and the filing of an application for renewal. If the application for renewal
is not made and the fee paid before September 1st, of the odd numbered year, the
license shall lapse and shall not be renewed. An application for reinstatement shall
be required. Reinstatement shall be at the sole discretion of the Board.
(g) Changes in any information in this section shall be submitted to the Board prior to
such change.
(4) Minimum Qualifications.
(a) The Board will consider the following factors in determining eligibility for
licensure for persons who engage in the wholesale distribution of prescription
drugs:
1. Any convictions of the applicant under any Federal, State, or local laws
relating to drug samples, wholesale or retail drug distribution, or distribution
of controlled substances;
2. Any felony convictions of the applicant under Federal, State, or local laws;
3. The applicant's past experience in the manufacture or distribution of
prescription drugs, including controlled substances;
4. The furnishing by the applicant of false or fraudulent material in any
application made in connection with drug manufacturing or distribution;
5. Suspension or revocation by Federal, State, or local government of any
license currently or previously held by the applicant for the manufacture or
distribution of any drugs, including controlled substances;
6. Compliance with licensing requirements under previously granted licenses,
if any;
7. Compliance with requirements to maintain and/or make available to the
State Licensing Authority or to Federal, State, or local law enforcement
officials, those records required to be maintained by drug wholesale
distributors; and
8. Any other factors or qualifications the Board considers relevant to and
consistent with the public health and safety.
(b) The Board reserves the right to deny a license to any applicant if it determines that
the granting of such a license would not be in the public's interest.
(5) Personnel. The licensed wholesale distributor shall employ adequate personnel with the
education and experience necessary to safely and lawfully engage in the wholesale
distribution of drugs.
(6) Violations:
(a) A license issued to a wholesale distributor pursuant to this part shall be subject to
revocation or suspension upon conviction of the license holder for violations of
Federal, State, or local drug laws and/or regulations.
(b) Violation of any of the provisions of any applicable Board laws or rules shall be
grounds for the suspension or revocation of the license issued hereunder.
(c) Any revocation or suspension of a license pursuant to this part shall be carried out
pursuant to the Georgia Administrative Procedure Act, O.C.G.A. Title 50 Chapter
13.
(d) Drug samples shall not be sold in any licensed pharmacy.
(7) Minimum Requirements for the Storage and Handling of Prescription Drugs and for the
Establishment and Maintenance of Prescription Drugs Distribution Records. The
following are required for the storage and handling of prescription drugs, and for the
establishment and maintenance of prescription drug distribution records by wholesale
drug distributors and their officers, agents, representatives, and employees.
(a) Facilities. All facilities at which prescription drugs are stored, warehoused,
handled, held, offered, marketed, or displayed shall:
1. Be of suitable size and construction to facilitate cleaning, maintenance, and
proper operations;
2. Have storage areas designed to provide adequate lighting, ventilation,
temperature, sanitation, humidity, space, equipment, and security
conditions;
3. Have a quarantine area for storage or prescription drugs that are outdated,
damaged, deteriorated, misbranded, or adulterated, or that are in immediate
or sealed, secondary containers that have been opened;
4. Be maintained in a clean and orderly condition; and
5. Be free from infestation by insects, rodents, birds, or vermin of any kind.
(b) Security. All facilities used for wholesale drug distribution shall be secure from
unauthorized entry.
1. Access from outside the premises shall be kept to a minimum and be well
controlled.
2. The outside perimeter of the premises shall be well lighted.
3. Entry into areas where prescription drugs are held shall be limited to
authorized personnel.
4. All facilities shall be equipped with an alarm system to detect entry after
hours.
5. All facilities shall be equipped with a security system that will provide
suitable protection against theft and diversion. When appropriate, the
security system shall provide protection against theft or diversion that is
facilitated or hidden by tampering with computers or electronic records.
(c) Storage. All prescription drugs or chemicals shall be stored at appropriate
temperatures and under appropriate conditions in accordance with requirements, if
any, in the labeling of such drugs, or with requirements in the current edition of an
official compendium, such as the United States Pharmacopeia (USP)
Compendium.
1. If no storage requirements are established for a prescription drug, the drug
may be held at "controlled" room temperature, as defined in the official
compendium, to help ensure that its identity, strength, quality, and purity are
not adversely affected.
2. Appropriate manual, electromechanical, or electronic temperature and
humidity recording equipment, devices, and/or logs shall be utilized to
document proper storage of prescription drugs.
3. The record keeping requirements in subparagraph (f) of this section shall be
followed for all stored drugs.
(d) Examination of materials.
1. Upon receipt, each outside shipping container shall be visually examined for
identity and to prevent the acceptance of contaminated prescription drugs or
prescription drugs that are otherwise unfit for distribution. This examination
shall be adequate to reveal container damage that would suggest possible
contamination or other damage to the contents.
2. Each outgoing shipment shall be carefully inspected for identity of the
prescription drug products and to ensure that there is no delivery of
prescription drugs that have been damaged in storage or held under
improper conditions.
3. The record keeping requirements in subparagraph (f) of this section shall be
followed for all incoming and outgoing prescription drugs.
(e) Returned, damaged, and outdated prescription drugs.
1. Prescription drugs that are outdated, damaged, deteriorated, misbranded, or
adulterated shall be quarantined and physically separated from other
prescription drugs until they are destroyed or returned to their supplier.
2. Any prescription drugs whose immediate or sealed outer or sealed
secondary containers have been opened or used shall be identified as such,
and shall be quarantined as such, and shall be quarantined and physically
separated from other prescription drugs until they are either destroyed or
returned to the supplier.
3. If the conditions under which a prescription drugs has been returned cast
doubt on the drug's safety, identify, strength, quality, or purity, then the drug
shall be destroyed, or returned to the supplier, unless examination, testing,
or other investigation proves that the drug meets appropriate standards of
safety, identity, strength, quality, and purity. In determining whether the
conditions under which the drug has been returned cast doubt on the drug's
safety, identity, strength, quality, or purity, the wholesale drug distributor
shall consider, among other things, the conditions under which the drugs has
been held, stored, or shipped before or during its return and the condition of
the drug and its container, carton, or labeling as a result of storage or
shipping.
4. The record keeping requirements in subparagraph (f) of this section shall be
followed for all outdated, damaged, deteriorated, misbranded, or adulterated
prescription drugs.
(f) Record keeping:
1. Wholesale drug distributors shall establish and maintain inventories and
records of all transactions regarding the receipt and distribution or other
disposition of prescription drugs. These records shall include the following
information:
(i) The source of the drugs, including the name and principal address of
the seller or transferor, and the address of the location from which the
drugs are shipped;
(ii) The identity and quantity of the drugs received and distributed or
disposed of; and
(iii) The date of receipt and distribution or other disposition of the drugs.
(g) For each person or firm, whether located inside or outside the State of Georgia, to
which a drug wholesale distributor, located inside the State of Georgia, sells to,
ships to, delivers to, or otherwise distributes drugs to, such drug wholesale
distributor shall request and maintain a copy of that person or firm's current
license or permit which authorizes them to purchase, buy, receive, or otherwise
possess drugs.
1. No drug wholesale distributor, located inside the State of Georgia, may ship
to, sell to, or otherwise deliver a dangerous drug or controlled substance to a
person or firm unless that person or firm holds a license or permit which
authorizes them to purchase, buy, receive or otherwise possess drugs.
(h) Nothing in this chapter or Georgia law authorizes any drug wholesale distributor,
located inside the State of Georgia, to sell, ship, or otherwise distribute any drugs
to any person or firm located outside the United States of America or its territories
without first receiving written permission to do so from the Board. Such
permission can only be granted by the Board after it has received a written request
from the drug wholesale distributor giving the details of the proposed transaction.
The Board reserves the right to have the GDNA investigate any and all such
requests, and the Board reserves the right to deny any such request.
(i) Inventories and all records required under this rule shall be made available for
inspection and photocopying by any authorized official of a government agency
charged with enforcement of these regulations for a period of two (2) years
following deposition of the drugs.
(j) Records described in this rule that are kept at the inspection site or that can be
immediately retrieved by computer or other electronic means shall be made readily
available for authorized inspection during the retention period. Records kept at a
central record keeping location apart from the inspection site and not electronically
retrievable, shall be made available for inspection within two (2) working days of a
request by an authorized official of any governmental agency charged with
enforcement of these regulations.
(8) Written Policies and Procedures. Wholesale drug distributors shall establish, maintain,
and adhere to written policies and procedures, which shall be followed for the receipt,
security, storage, inventory, and distribution of prescription drugs, including policies and
procedures for identifying recording, and reporting losses or thefts, and for correcting all
errors and inaccuracies in inventories. Wholesale drug distributors shall include in their
written policies the following:
(a) A procedure whereby the oldest approved stock of a prescription drug product is
distributed first. The procedure may permit deviation from this requirement, if
such deviation is temporary and appropriate.
(b) A procedure to be followed for handling recalls and withdrawals of prescription
drugs. Such procedure shall be adequate to deal with recalls and withdrawals due
to:
1. Any action initiated at the request of the FDA or other Federal, State, or
local law enforcement or other government agency, including the Georgia
State Board of Pharmacy;
2. Any voluntary action by the manufacturer to remove defective or potentially
defective drugs from the market; or
3. Any action undertaken to promote public health and safety by replacing of
existing merchandise with an improved product or new package design.
(c) A procedure to ensure that wholesale drug distributors prepare for, protect against,
and handle any crisis that affects security or operation of any facility in the event
of strike, fire, flood, or other natural disaster, or other situations of local, state, or
natural emergency.
(d) A procedure to ensure that any outdated prescription drugs shall be segregated
from other drugs and either returned to the manufacturer or destroyed. This
procedure shall provide for written documentation of the disposition of outdated
prescription drugs. This documentation shall be maintained for two (2) years after
disposition of the outdated drugs.
(9) Responsible persons. Wholesale drug distributors shall establish and maintain lists of
officer, directors, managers, and other persons in charge of wholesale drug distribution,
storage, and handling, including a description of their duties and a summary of their
qualifications.
(10) Compliance with Federal, State, and local laws. Wholesale drug distributors shall
operate in compliance with applicable Federal, State, and local laws and regulations.
(a) Wholesale drug distributors shall permit the Georgia State Board of Pharmacy
and authorized Federal, State, and local law enforcement officials to enter and
inspect their premises and delivery vehicles, and to audit their records and
written operation procedures, at reasonable times and in a reasonable manner, to
the extent authorized by law.
(b) Wholesale drug distributors that deal in controlled substances shall register with
the appropriate State controlled substance authority and with the Drug
Enforcement Administration (DEA), and shall comply with all applicable State,
Local, and DEA regulations.
(11) Salvaging and reprocessing. Wholesale drug distributors shall be subject to the
provisions of any applicable Federal, State or local laws or regulations that relate to
prescription drug product salvaging or reprocessing.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.